Danaher Corporation (DHR)
NYSE: DHR · IEX Real-Time Price · USD
267.56
+1.76 (0.66%)
May 20, 2024, 12:13 PM EDT - Market open
Danaher Revenue
Danaher had revenue of $22.52B in the twelve months ending March 29, 2024, down -9.58% year-over-year. Revenue in the quarter ending March 29, 2024 was $5.80B, a -2.57% decrease year-over-year. In the year 2023, Danaher had annual revenue of $23.89B, a decrease of -10.33%.
Revenue (ttm)
$22.52B
Revenue Growth
-9.58%
P/S Ratio
8.80
Revenue / Employee
$357,444
Employees
63,000
Market Cap
198.13B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
| Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
| Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
| Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
| Dec 31, 2014 | 12.87B | -5.42B | -29.62% |
| Dec 31, 2013 | 18.28B | 22.70M | 0.12% |
| Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
| Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
| Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
| Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
| Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
| Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
| Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
| Dec 31, 2005 | 7.87B | 982.20M | 14.26% |
| Dec 31, 2004 | 6.89B | 1.60B | 30.14% |
| Dec 31, 2003 | 5.29B | 716.64M | 15.66% |
| Dec 31, 2002 | 4.58B | 794.79M | 21.01% |
| Dec 31, 2001 | 3.78B | 4.67M | 0.12% |
| Dec 31, 2000 | 3.78B | 580.54M | 18.16% |
| Dec 31, 1999 | 3.20B | 150.18M | 4.93% |
| Dec 31, 1998 | 3.05B | 427.96M | 16.34% |
| Dec 31, 1997 | 2.62B | 385.91M | 17.28% |
| Dec 31, 1996 | 2.23B | 746.42M | 50.20% |
| Dec 31, 1995 | 1.49B | 372.80M | 33.47% |
| Dec 31, 1994 | 1.11B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck & Co. | 61.40B |
| Pfizer | 55.09B |
| AbbVie | 54.40B |
| Novartis AG | 49.92B |
| AstraZeneca | 47.61B |
| Thermo Fisher | 42.49B |
| Abbott Laboratories | 40.33B |
| Amgen | 29.53B |
DHR News
- 11 days ago - Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis - PRNewsWire
- 12 days ago - Danaher to Present at Bank of America Securities Healthcare Conference - PRNewsWire
- 12 days ago - Danaher Announces Quarterly Dividend - PRNewsWire
- 17 days ago - Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry - PRNewsWire
- 19 days ago - The Forgotten Stock Advice That Delivers 170%+ Payout Growth - Forbes
- 24 days ago - What Should You Do With Danaher Stock At $250 After Q1 Beat? - Forbes
- 27 days ago - Danaher Shrugs Off Outlook for Falling Sales - Barrons
- 27 days ago - Danaher beats quarterly estimates on strength in diagnostics business - Reuters